The project Microchip-based Functional Leukocyte Testing for Immunotherapy, led by Olivier Theodoly and Philippe Robert, has been selected as a 2025 Canceropôle Provence-Alpes-Côte d’Azur grant recipient.

The project is based on an innovative technology developed at the Laboratory of Adhesion & Inflammation (LAI) in Marseille and the Interdisciplinary Institute for Neurosciences (IINS) in Bordeaux, patented in collaboration with CNRS Innovation. Using molecular microprinting, this approach enables the fabrication of microchips with precisely controlled amounts and micrometer-scale patterns of multiple antibodies.

The goal is to make these microchips suitable for routine hospital use, providing a more accessible alternative to conventional techniques, which are often costly and time-consuming for hospital technicians. By developing these new tools, this project contributes to advancing rapid diagnostic solutions and personalized patient monitoring in immunotherapy.

The awardees were honored at a special event hosted by Canceropôle Provence-Alpes-Côte d’Azur on January 31, 2025, at the Musée Regards de Provence in Marseille.

Learn more: https://bit.ly/40ZFvZW